U.S Department of Health & Human ServicesHHSNational Institutes of HealthNIHNCATSNCATSCTSA ProgramCTSA
CTSA CCOS

Coordination, Communication, and Operations Support

RegisterLog In
CTSA News
Need Help

CTSA News

CTSA News

Announcements

Date

December 29, 2023

Share this News Post

Stanford CTSA Colloquium on Research Rigor and Reproducibility on January 29th

The Stanford CTSA’s Program on Research Rigor & Reproducibility (SPORR), will be hosting a Rigor and Reproducibility Colloquium: Conversations on how to future-proof our science on January 29th, 2024.    

 

The Colloquium will focus on the efforts of several CTSA institutions to strengthen the robustness, validity, and transparency of research. It will feature plenary talks from Dr. Geeta K. Swamy (Associate Vice President for Research, and Vice Dean for Scientific Integrity at Duke University) and Dr. Alexa McCray (Professor of Medicine, Harvard Medical School), together with panel discussions with Stanford faculty and participation of attendees.  

 

SPORR will also present the findings of their recently conducted CTSA wide survey on Rigor & Reproducibility training, as well as showcase support, monitoring, and educational programs in place at the Stanford School of Medicine. Rigor and Reproducibility (RaRe) Investigator awards will be presented for Stanford individuals or teams who have demonstrated excellence in those domains.  

 

The Colloquium is free to attend in person or virtually, but registration is required. More details about the Colloquium can be found at the SPORR Colloquium website, where a link will be made available a few days before the event for those who want to join through Zoom.   

 

SPORR, directed by Associate Dean Steven Goodman, M.D., M.H.S., Ph.D., is part of Spectrum, Stanford’s Center for Clinical and Translational Research and Education, directed by Dr. Ruth O’Hara.

Northwestern University CTSI Breaking Barriers: Celebrating Thirty Years of the NIH Revitalization Act and Women's Health Research

Previous

Hormone Replacement Therapy Reduces the Risk of Serious Complications after COVID-19 in Immunocompetent Males and Females, but not in Immunosuppressed Transplant Recipients

Next

Coordination, Communication, and Operations Support (CCOS) is funded by theNational Center for Advancing Translational Sciences, National Institutes of Health.

HomeContact UsPrivacy PolicyAccessibility Statement
Freedom of Information (FOIA)Office of Inspector General (OIG)Cookie Preference
X-TwitterLinkedIn icon